13.07.2015 Views

url?sa=t&source=web&cd=2&ved=0CC0QFjAB&url=http://filletofish.net/usc/Pocket_Medicine_4th_Edition

url?sa=t&source=web&cd=2&ved=0CC0QFjAB&url=http://filletofish.net/usc/Pocket_Medicine_4th_Edition

url?sa=t&source=web&cd=2&ved=0CC0QFjAB&url=http://filletofish.net/usc/Pocket_Medicine_4th_Edition

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Other• Behavior modification: identify and avoid triggers• Immunotherapy (eg, desensitization): may be useful if significant allergic component• TNF antagonists may be helpful in Pts w/ refractory asthma (NEJM 2006;354:697)• Anti-IL5 found to spare steroids in uncontrolled Pts w/ sputum eos (NEJM 2009;360:985)• Bronchial thermoplasty (exp’tal): radiofrequency destruction of airway smooth m<strong>usc</strong>leno in FEV 1, but T in sx and # of exacerbations (NEJM 2007;356:1327)• PPI: not found to improve asthma sx, even if asx GERD (NEJM 2009;360:1487)Principles of treatment• Education and avoidance of environmental triggers for all Pts• Use quick-relief rescue medication as needed for all Pts• Goal is to achieve complete control daily sx 2/wk, ∅ nocturnal sx or limitationof activity, reliever med 2/wk, nl PEF or FEV 1; partly controlled 1–2 of theabove present in a wk; uncontrolled 3 of the above present in a wk• Step up treatment as needed to gain control, step down as tolerated• If PEF T 15% 2 d or T 30%, quadrupling inh steroid dose S Tneed for PO steroids(AJRCCM 2009;180:598)Asthma Stepwise TherapyStep 1 Step 2 Step 3 Step 4 Step 5Rapid-acting 2-agonists prnSelect one Select one Do one or more Add one or bothLow-dose Low-dose ICS low-dose ICS to Oral steroidsICS LABA med/high dose (w/LABA) (lowest dose)LTA Med/high-dose ICS Add LTA Anti-IgE RxLow-dose ICS LTA Add TheoLow-dose ICS TheoICS, inh corticosteroid; LABA, long-acting 2-agonist; LTA, leukotriene antag.;Theo, sustained-rel. theophyllineBoldfaced Rx preferred options. (Adapted from Global Initiative for Asthma [GINA] 2009)Controller optionsEXACERBATIONDirect evaluation• HistoryAsthma Hx: baseline PEF, steroid requirement, ED visits, hospital admissions;previous need for intubation a good predictor of risk of death (Thorax 1986;41:833)Current exacerbation: duration, severity, potential precipitants, meds used• Physical examSigns of severity: tachypnea, tachycardia, diaphoresis, cyanosis, fragmented speech,absent breath sounds, accessory m<strong>usc</strong>le use, pulsus paradoxus, abdominal paradoxAssess for barotrauma: asymmetric breath sounds, tracheal deviation, subcutaneousair S pneumothorax, precordial (Hamman’s) crunch S pneumomediastinum• Diagnostic studiesABG: not always considered essential because exam and S aO 2 provide equivalent info;low P aCO 2 initially; nl or high P aCO 2 may signify tiring; may respond to bronchodilatorPEF: used to follow clinical course; CXR: not essential unless suspicion for PNA or PTXSeverity of Asthma ExacerbationFeature Mild Moderate SevereBreathless w/ . . . Walking Talking At restTalking in . . . Sentences Phrases WordsMental status Agitated Agitated AgitatedRR c c 30Accessory m<strong>usc</strong>les ∅ Wheeze Moderate, end-expir Loud Usually loudHR 100 100–120 120Pulsus paradoxus Normal (10) 10–25 25PEF 80% 60–80% 60%S aO 2 95% 91–95% 90%P aO 2 Normal 60 60P aCO 2 45 45 45Presence of several parameters (not necessarily all) indicates classification (GINA 2009)Resp arrest imminent: drowsy, abdominal paradox, wheezes inaudible (b/c ∅ air movement), bradycardia,loss of abdominal paradox (respiratory m<strong>usc</strong>le fatigue).ASTHMA 2-3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!